Human Molecular Genetics, Vol 5, 755-761, Copyright © 1996 by Oxford University Press
NJ Van Orsouw, D Li, P van der Vlies, H Scheffer, C Eng, CH Buys, FP Li and J Vijg
With the rapid increase in the number of identified human disease genes,
the development of accurate and cost-efficient mutation tests has become
opportune. Here we present a combination of extensive PCR multiplexing and
two-dimensional (2-D) DNA electrophoresis to screen for mutations in 26
exons of the retinoblastoma (RB1) tumor suppressor gene. In 2-D
electrophoresis, fragments are separated according to size and base pair
sequence in non-denaturing and denaturing gradient gels, respectively. All
target fragments, designed to have optimal melting characteristics, were
prepared in a two-step PCR (a 6-plex long-PCR pre- amplification and a
subsequent 25-plex short-PCR) followed by heteroduplexing. The mixture of
PCR amplicons was then subjected to 2-D electrophoresis under a single set
of experimental conditions. With this design, 35 previously identified
mutations in 18 different exons were detected in 33 bilateral
retinoblastoma patients. These results suggest that 2-D electrophoresis in
this format provides a generally applicable, practical and fast way to
diagnose with high accuracy large genes for a broad spectrum of possible
disease-causing mutations.
ARTICLES
Mutational scanning of large genes by extensive PCR multiplexing and two-dimensional electrophoresis: application to the RB1 gene
Department of Medicine, Beth Israel Hospital, Boston, MA 02215, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. W. Haile, D. C. Thomas, V. McGuire, A. Felberg, E. M. John, R. L. Milne, J. L. Hopper, M. A. Jenkins, A. J. Levine, M. M. Daly, et al. BRCA1 and BRCA2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer Before Age 50 Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1863 - 1870. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J van Orsouw, R. K Dhanda, Y. Elhaji, S. A Narod, F. P Li, C. Eng, and J. Vijg A highly accurate, low cost test for BRCA1 mutations J. Med. Genet., October 1, 1999; 36(10): 747 - 753. [Abstract] [Full Text] |
||||

